Intracameral bevacizumab and mitomycin C Trabeculectomy for eyes with neovascular glaucoma: A case series

Journal of Ocular Biology, Diseases, and Informatics

Volumn 2, Issue 1, 2009, Pages 40-46

  De Moraes, Carlos Gustavo Vasconcelos ^a,b   Facio Jr , Antonio Carlos ^a   Costa, José Humberto ^a   Malta, Roberto Freire Santiago ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b NEW YORK EYE AND EAR INFIRMARY   (United States)

Author keywords

Bevacizumab; Intraocular pressure; Neovascular glaucoma; Trabeculectomy

Indexed keywords

ATROPINE; BEVACIZUMAB; MITOMYCIN C; MOXIFLOXACIN; PREDNISOLONE;

ADULT; AGED; ANTERIOR EYE CHAMBER; BIOMICROSCOPY; CLINICAL EVALUATION; CLINICAL TRIAL; DRUG DOSE REDUCTION; DRUG SAFETY; EYE INFLAMMATION; FEMALE; FOLLOW UP; HUMAN; INTRAOCULAR PRESSURE; LASER COAGULATION; MALE; NEOVASCULAR GLAUCOMA; OCULOPLETHYSMOGRAPHY; PILOT STUDY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; SURGICAL TECHNIQUE; THERAPY EFFECT; TRABECULECTOMY; TREATMENT OUTCOME; TREATMENT RESPONSE; VISUAL ACUITY;

EID: 67651250930     PISSN: None     EISSN: 19368445     Source Type: Journal    
DOI: 10.1007/s12177-009-9020-z     Document Type: Review

References (39)

1. JA Sivack-Callcott DM O'Day DM Gass 2001 Evidence based recommendations for the diagnosis and treatment of neovascular glaucoma Ophthalmology 108 1767 1776
2. Allingham RA, Damji KF, Freedman S, et al. Glaucomas associated with disorders of the retina, vitreous and choroids. In: Shields' Textbook of Glaucoma, 5th edn. Philadelphia: Lippincott, Williams & Wilkins; 2005.
3. Central Vein Occlusion Study Group 1997 Natural history and clinical management of central retinal vein occlusion Arch Ophthalmol 115 486 491
4. GW Aylward RV Pearson JD Jagger AM Hamilton 1989 Extensive argon laser photocoagulation in the treatment of proliferative diabetic retinopathy Br J Ophthalmol 73 197 201
5. BH Doft GW Blankenship 1982 Single vs multiple treatment sessions of argon laser panretinal photocoagulation for proliferative diabetic retinopathy Ophthalmology 89 772 779
6. SC Kaufman FL Ferris III DG Seigel 1989 Factors associated with visual outcome after photocoagulation for diabetic retinopathy: diabetic retinopathy study report 13 Invest Ophthalmol Vis Sci 30 23 28
7. AP Adamis JW Miller MT Bernal 1994 Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy Am J Ophthalmol 118 445 450
8. LP Aiello RL Avery PG Arrigg 1994 Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 331 1480 1487
9. J Pe'er D Shweiki A Itin 1995 Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases Lab Invest 72 638 645
10. PA Sidoti TR Dunphy G Baerveldt 1995 Experience with the Baerveldt glaucoma implant in treating neovascular glaucoma Ophthalmology 102 1107 1118
11. CH Hong A Arosemena D Zurakowski 2005 Glaucoma drainage devices: a systematic literature review and current controversies Surv Ophthalmol 50 48 60
12. JA Sivak-Callcott DM O'Day JD Gass 2001 Evidence-based recommendations for the diagnosis and treatment of neovascular glaucoma Ophthalmology 108 1767 1776
13. Takihara Y, Inatani M, Fukushima M, et al. Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure. Am J Ophthalmol. 2009, (in press).
14. Y Kiuchi R Sugimoto K Nakae 2006 Trabeculectomy with mitomycin C for treatment of neovascular glaucoma in diabetic patients Ophthalmologica 220 383 388
15. IS Yalvac U Eksioglu B Satana 2007 Long-term results of Ahmed glaucoma valve and Molteno implant in neovascular glaucoma Eye 21 65 70
16. Tube Versus Trabeculectomy Study Group 2005 The tube versus trabeculectomy study: design and baseline characteristics of study patients Am J Ophthalmol 140 275 287
17. RL Avery DJ Pieramici MD Rabena 2006 Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmology 113 363 365
18. MG Krzystolik MA Afshari AP Adamis 2002 Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment Arch Ophthalmol 120 338 346
19. PJ Rosenfeld AA Moshfeghi CA Puliafito 2005 Optical coherence tomography findings after an intravitreal injection of bevacizumab (Avastin) for neovascular age-related macular degeneration Ophthalmic Surg Lasers Imaging 36 331 335
20. JF Arevalo L Wu JG Sanchez 2007 Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up Eye 23 117 123
21. K Ishikawa S Honda Y Tsukahara 2007 Preferable use of intravitreal bevacizumab as a pretreatment of vitrectomy for severe proliferative diabetic retinopathy Eye 23 108 111
22. SS Lynch CM Cheng 2007 Bevacizumab for neovascular ocular diseases Ann Pharmacother 41 614 25
23. RA Costa R Jorge D Calucci 2007 Intravitreal bevacizumab (Avastin) for central and hemicentral retinal vein occlusions: IBeVO study Retina 27 141 149
24. RL Avery J Pearlman DJ Pieramici 2006 Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy Ophthalmology 113 1695
25. GB Jaissle F Ziemssen K Petermeier P Szurman M Ladewig 2006 Bevacizumab for treatment of macular edema secondary to retinal vein occlusion Ophthalmologe 103 471 475
26. F Bock Y Konig T Dietrich 2007 Inhibition of angiogenesis in the anterior chamber of the eye Ophthalmologe 104 336 344
27. C Kiss S Michels F Prager 2006 Evaluation of anterior chamber inflammatory activity in eyes treated with intravitreal bevacizumab Retina 26 877 881
28. ME Gheith GA Siam DS De Barros 2007 Role of intravitreal bevacizumab in neovascular glaucoma J Ocul Pharmacol Ther 23 487 491
29. MN Chilov JR Grigg TJ Playfair 2007 Bevacizumab (Avastin) for the treatment of neovascular glaucoma Clin Exp Ophthalmol 35 494 496
30. F Batioglu N Astam E Ozmert 2007 Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma Int Ophthalmol 28 59 61
31. S Grisanti S Biester S Peters 2006 Tuebingen Bevacizumab Study Group. Intracameral bevacizumab for iris rubeosis Am J Ophthalmol 142 158 160
32. JB Jonas UH Spandau F Schlichtenbrede 2007 Intravitreal bevacizumab for filtering surgery Ophthalmic Res 39 121 122
33. MJ Lavin RP Wormald CS Migdal 1990 The influence of prior therapy on the success of trabeculectomy Arch Ophthalmol 108 1543 1548
34. AU Bayer C Erb F Ferrari 1995 The Tubingen Glaucoma Study. Glaucoma filtering surgery-a retrospective long-term follow-up of 254 eyes with glaucoma Ger J Ophthalmol 4 289 293
35. PC Jacobi TS Dietlein GK Krieglestein 1999 Primary trabeculectomy in young adults: long-term clinical results and factors influencing the outcome Ophthalmic Surg Lasers 30 637 646
36. MY Kahook JS Schuman RJ Noecker 2006 Needle bleb revision of encapsulated filtering bleb with bevacizumab Ophthalmic Surg Lasers Imaging 37 148 150
37. ME Iliev D Domig U Wolf-Schnurrbursch 2006 Intravitreal bevacizumab (Avastin) in the treatment of neovascular glaucoma Am J Ophthalmol 142 1054 1056
38. A Miki Y Oshima Y Otori 2008 Efficacy of intravitreal bevacizumab as adjunctive treatment with pars plana vitrectomy, endolaser photocoagulation, and trabeculectomy for neovascular glaucoma Br J Ophthalmol 92 1431 1433
39. T Wakabayashi Y Oshima H Sakaguchi 2008 Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases Ophthalmology 115 1571 1580